Tempus

About Tempus

Tempus is headquartered in Chicago, Illinois, and was founded in 2015 by Eric Lefkofsky.

History

Tempus was founded in 2015 with the mission to bring the power of artificial intelligence to healthcare. The company started by focusing on oncology and has since expanded to other therapeutic areas. In 2019, Tempus went public and has continued to grow its data library and AI capabilities.

Mission

To bring the power of artificial intelligence to healthcare by building the world's largest library of clinical and molecular data and making that data accessible and useful for physicians, researchers, and patients.

Vision

To enable precision medicine at scale by democratizing access to clinical and molecular data through artificial intelligence and machine learning.

Values

• Patient-centricity: Putting patients at the center of everything they do
• Scientific rigor: Maintaining the highest standards of scientific excellence
• Data privacy and security: Protecting patient data with the utmost care
• Innovation: Continuously pushing the boundaries of what's possible
• Collaboration: Working together with healthcare providers and researchers

Products and Services

Tempus offers a comprehensive suite of products including genomic sequencing, AI-powered clinical decision support tools, real-world data analytics, and clinical trial matching services. Their platform serves oncologists, pathologists, researchers, and pharmaceutical companies.

Latest Technologies and Trends

Tempus is at the forefront of precision medicine, leveraging advanced AI algorithms, multimodal data analysis, and real-world evidence generation. The company is expanding into new therapeutic areas and developing next-generation sequencing technologies.

Interesting Facts

Tempus has partnerships with major healthcare systems and has processed millions of patient records. The company's AI models have been validated in numerous peer-reviewed publications and continue to drive innovations in personalized medicine.